Most mitochondrial proteins possess N-terminal presequences that are required for targeting and import into the organelle. Upon import, presequences are cleaved off by matrix processing peptidases and subsequently degraded by the peptidasome Cym1/ PreP, which also degrades Amyloid-beta peptides (Ab). Here we find that impaired turnover of presequence peptides results in feedback inhibition of presequence processing enzymes. Moreover, Ab inhibits degradation of presequence peptides by PreP, resulting in accumulation of mitochondrial preproteins and processing intermediates. Dysfunctional preprotein maturation leads to rapid protein degradation and an imbalanced organellar proteome. Our findings reveal a general mechanism by which Ab peptide can induce the multiple diverse mitochondrial dysfunctions accompanying Alzheimer's disease.
INTRODUCTION
The vast majority of mitochondrial proteins is nuclear-encoded and has to be imported into the organelle from the cytosol. Approximately two-thirds of all mitochondrial preproteins possess N-terminal presequences that direct them to the mitochondrial import machineries (Neupert and Herrmann, 2007; Chacinska et al., 2009; Vö gtle et al., 2009 ). Upon import, presequences are typically cleaved by the mitochondrial processing peptidase MPP in the matrix releasing the mature protein (Hawlitschek et al., 1988; Yang et al., 1991; Vö gtle et al., 2009) . In several cases, MPP generates import intermediates that are further processed by the octapeptidyl peptidase Oct1/MIP or the intermediate cleaving peptidase Icp55 (Vö gtle et al., 2009 , 2011 Mossmann et al., 2012; Teixeira and Glaser, 2013) . Incomplete processing of mitochondrial preproteins leads to their destabilization and accelerated turnover (Yang et al., 1991; Mukhopadhyay et al., 2007; Vö gtle et al., 2009 Vö gtle et al., , 2011 Varshavsky, 2011) . Presequence peptides that have been cleaved by MPP are subsequently degraded by the matrix peptidasome Cym1/ PreP, a metallopeptidase of the pitrilysin family M16 (Alikhani et al., 2011a) . PreP catalyzes turnover of peptides larger than 11 amino acids as well as unstructured proteins (Stahl et al., 2002) . Recently, it has been shown that PreP also degrades amyloid-beta (Ab) peptides that were reported to accumulate in mitochondria of Alzheimer's disease (AD) patients, and a decline in PreP activity has been observed in AD mitochondria (Manczak et al., 2006; Falkevall et al., 2006; Hansson Petersen et al., 2008; Alikhani et al., 2011b) . Ab import depends on the mitochondrial import machinery (Hansson Petersen et al., 2008) . Mitochondrial Ab appears to affect a multitude of different functions in AD, including respiration, detoxification of reactive oxygen species (ROS), and organellar morphology (Lustbader et al., 2004; Manczak et al., 2006; Yao et al., 2009; Rhein et al., 2009; Morais and De Strooper, 2010; Selfridge et al., 2013) . How a single peptide like Ab can impair all of these diverse, important mitochondrial functions remaines elusive.
Here, we investigated the effects of impaired peptide turnover and of Ab peptide accumulation on mitochondrial functions. We report that mitochondrial preprotein maturation depends on efficient peptide degradation. Moreover, we find that mitochondrial Ab leads to inhibition of peptide turnover, thereby causing accumulation of nonprocessed preproteins and processing intermediates within mitochondria. Impaired preprotein maturation modulates protein turnover and changes the global organellar protein composition, which might finally explain the pleiotropic mitochondrial defects observed in AD mitochondria.
RESULTS

Mitochondrial Presequence Processing Depends on Peptide Turnover
In order to analyze the physiological impact of peptide turnover on mitochondrial functions, we characterized a yeast mutant that lacks the PreP homolog Cym1 (Kambacheld et al., 2005) . We isolated mitochondria from cym1D and wild-type strains and analyzed various mitochondrial proteins by western blotting. Several proteins showed a strong accumulation of their precursor forms and processing intermediates as well as decreased levels of cleaved, mature proteins in cym1D mitochondria in comparison to wild-type ( Figure 1A ). An antibody raised against the presequence peptide of Sod2 revealed a specific signal of the precursor form in cym1D mitochondria, but not in wild-type ( Figure 1B) . Analysis of cym1 mutants that lack critical residues of the metal binding motif (HXXEH) (Table S1, available online; Kambacheld et al., 2005) indicated that accumulation of precursor proteins depends on Cym1 protease activity ( Figure 1C ). This implied that impaired peptide degradation in cym1D might affect the presequence processing activity of MPP. To further support this assumption, we performed a global mass spectrometric analysis of mitochondrial N termini in cym1D mitochondria using COFRADIC (combined fractional diagonal chromatography) (Vö gtle et al., 2009) (Table S2) . Indeed, a large number of N termini in cym1D mitochondria corresponded to nonprocessed preproteins or processing intermediates of dually processed proteins when compared to the N-proteome of wild-type mitochondria (Tables  S2 and S3 ) (Vö gtle et al., 2009) . We conclude that the lack of the peptidasome Cym1 leads to impaired preprotein maturation in vivo.
As an additional assay to link preprotein maturation and peptide turnover, we generated a yeast mutant that lacks Cym1 and harbors a temperature-sensitive allele of the essential MPP subunit Mas1 (Hawlitschek et al., 1988; Yang et al., 1991; Vö gtle et al., 2009 ). The mutant was not able to grow under respiratory conditions (i.e., when mitochondrial energy metabolism is essential for cell viability), indicating a genetic interaction of the presequence peptidase MPP and the peptidasome Cym1 ( Figure 1D ).
The proteins that were accumulating as precursors or processing intermediates in cym1D samples encompass a variety of mitochondrial functions, including respiration, ATP synthesis, mtDNA maintenance, and gene expression or oxidative stress response (Table S3 ; Figures 1A and 1B) . Assessment of various mitochondrial functions in cym1D mitochondria revealed increased levels of ROS, decreased membrane potential, and impaired O 2 consumption compared to wild-type ( Figure S1A ).
Remarkably, similar diverse mitochondrial dysfunctions have been observed in mitochondria from AD patients and AD mouse models (Morais and De Strooper, 2010; Manczak et al., 2006; Rhein et al., 2009; Alikhani et al., 2011b) . These results indicate that physiological consequences of impaired mitochondrial peptide turnover activity correlate with pathological phenotypes observed in AD mitochondria.
To test if presequence processing is affected in the absence of Cym1, we performed in organello imports of radiolabelled preproteins into isolated mitochondria of wild-type and cym1D yeast cells. Presequence processing of Sod2 preprotein was impaired in cym1D mitochondria, and nonprocessed preprotein accumulated as a Proteinase K-resistant form within the organelle ( Figure S1B ). Similar defects were observed when import was performed in mas1 mitochondria ( Figure S1C ). The general import efficiency of the presequence import pathway was not compromised in cym1D or mas1 mitochondria (tested by the nonprocessed Hsp10 preprotein) (Figures S1B and S1C). The processing defect in cym1D appeared to be specific for MPP because presequence cleavage of Mrpl32 that does not depend on MPP (Nolden et al., 2005) was fully functional in cym1D mitochondria ( Figure S1D ). To directly analyze the dependency of preprotein maturation on peptide turnover, we employed an in vitro processing assay in mitochondrial extracts ( Figure S1E ) (Falkevall et al., 2006 ) from wild-type and cym1D mitochondria. This allowed the analysis of presequence processing independent of protein import. Presequence peptides were rapidly degraded in wild-type, but not cym1D, extracts ( Figure S1F ). In the presence of a typical presequence peptide (Cox4 preseq. ) (Yang et al., 1991) , the in vitro processing of radiolabelled Sod2 precursor by MPP was efficiently blocked in the absence of Cym1 ( Figure 1E ). Cox4 presequence peptides were able to inhibit purified MPP in similar concentrations (Figures S1G and S1H) (Yang et al., 1991) . To exclude that the impaired presequence processing activity in cym1D is caused by an indirect effect, we added cell-free translated Cym1 protein to the in vitro processing assay. We found that MPP processing activity was restored in cym1D extracts in the presence of Cym1 protein, indicating a direct functional link between Cym1 activity and presequence processing ( Figure 1F ). In addition, overexpression of MPP in the cym1D strain, as well as presence of purified MPP in mitochondrial extracts of cym1D, was able to suppress the impaired preprotein processing activity (Figures S1I and S1J). We conclude that impaired turnover of presequence peptides leads to inhibition of MPP processing activity. This functional coupling explains the preprotein accumulation observed in cym1D mitochondria in vivo (Figures 1A and 1B ; Table S3 ).
Maturation of Precursor Processing Intermediates Depends on Cym1
We wondered why preprotein processing intermediates also accumulated in the cym1D mutant ( Figure 1A ). It has been proposed that PreP/Cym1 requires a minimal substrate length of 11 amino acids (Stahl et al., 2002) . However, the intermediate peptidase Oct1 cleaves off octapeptides (Vö gtle et al., 2011) . We constructed an oct1Dcym1D double mutant, and the observed synthetic growth defect pointed to a functional link between both enzymes (Figure 2A ). Furthermore, we found that processing activity of purified MPP was not affected in the presence of octapeptides (derived from the Oct1 substrate Sdh1; Figure 2B ). In contrast, the presence of a presequence peptide efficiently inhibited MPP activity ( Figure S1H ). However, in vitro processing of the Cox4 precursor that is cleaved sequentially by MPP and Oct1 revealed a specific impairment of the Oct1-dependent processing step in cym1D in the presence of octapeptides ( Figure 2C ). This indicated that Cym1 activity is also affected by accumulation of octapeptides and that an impaired turnover of MPP generated presequences, and Oct1-derived octapeptides leads to inhibition of presequence processing, causing accumulation of preproteins as well as processing intermediates.
To investigate the functional consequences of impaired presequence processing activity, we employed mitochondria from the temperature-sensitive mas1 strain that had been shifted to nonpermissive growth temperature for 24 hr to inactivate MPP activity in vivo. Western blot analysis revealed an accumulation of nonprocessed preproteins and reduced levels of mature proteins similar to the phenotype observed in cym1D mitochondria ( Figure 2D ). Thus, inactivation of either peptide turnover (cym1D) or presequence processing (mas1) leads to the phenotype of impaired preprotein maturation and reduced amounts of mature proteins ( Figures 1A, 1B, and 2D ).
Ab Impairs Mitochondrial Peptide Turnover, Leading to Feedback Inhibition of Presequence Processing Next, we asked if Ab peptide that accumulates in mitochondria of AD patients and represents a substrate of human PreP might cause a delay in matrix peptide degradation and thereby induce feedback inhibition of presequence processing enzymes. We found that Ab peptide was degraded by Cym1 in mitochondrial extracts and by the recombinant enzyme ( Figures 3A and 3B) . However, degradation of Ab was slower compared to turnover of presequence peptides ( Figure S2A ). We then analyzed degradation of Cox4 presequence peptides in wild-type mitochondrial extracts and found that the presence of Ab, but not of a scrambled form, impaired the peptide turnover capacity of Cym1 (Figure 3C , lanes 5-13 versus 18-26). Scrambled Ab was not degraded by Cym1 ( Figure S2B ). We further asked if Ab can also affect presequence processing activity of MPP. We tested the processing of radiolabelled Sod2 preprotein and observed a striking delay in presequence processing in the presence of Ab ( Figure 3D ). We noticed that Ab 1-40 (unlike the shorter version ) slightly inhibited activity of purified MPP at higher concentrations ( Figures S2C and S2D ) and therefore included the shorter version in our functional assays. Taken together, our findings show that Ab peptide inhibits peptide turnover in mitochondrial extracts, which causes impaired maturation of preproteins.
Mitochondrial Ab Inhibits Precursor Maturation In Vivo
To analyze the effect of Ab on precursor maturation in vivo, we attempted to reconstitute the entire mechanism described above in a yeast model that allowed galactose-induced expression of an eGFP-Ab 1-42 fusion protein harboring a cleavage site for TEV protease ( Figure 4A ). Coexpression of TEV protease led to release of Ab peptides from the fusion protein ( Figure S3A ). To analyze Ab-induced mitochondrial dysfunctions, we employed the aging-prone strain coa6D, which showed a moderate instability of respiratory chain complexes in order to mimick conditions in aged humans (Larsson, 2010; Vö gtle et al., 2012) , and induced eGFP-Ab 1-42 expression by growth on galactose.
Ab localized to mitochondria ( Figures S3B and S3C ) and impaired maturation of Sod2 precursor in soluble mitochondrial extracts ( Figures 4B and 4C ). The presequence import pathway was not compromised by Ab ( Figure S3D ). After induction for 3 days, we observed accumulation of several precursor proteins in mitochondria of the Ab-expressing strain ( Figure 4C ), indicating that Ab inhibits preprotein maturation in vivo. After induction for 5 days, several mitochondrial dysfunctions were observed in mitochondria isolated from the Ab-expressing strain compared to the control strain. This included increased levels of ROS, a decrease in membrane potential, and impaired oxygen consumption ( Figure S3E ). Overexpression of Cym1 in the Ab-expressing strain led to an increased turnover of Ab, substantial reduction of the accumulating preproteins in vivo ( Figure S3F ), and increased MPP processing activity in vitro (Figure S3G) . We conclude that Ab-mediated inhibition of the peptidasome Cym1 leads to an impaired presequence processing activity of MPP, which results in accumulation of preproteins in vivo. As a further in vivo system, we tested freshly isolated matrix extracts from brain mitochondria of PS2APP mice. This AD model harbors mutations in the PS2 (N141I) and APP (Swedish FAD) genes and shows Ab accumulation in mitochondria (Figure S3H) (Rhein et al., 2009; Ozmen et al., 2009 ). Indeed, processing of the Cox4 preprotein was significantly impaired in PS2APP samples compared to that in age-matched wild-type mice ( Figure 4D ).
Finally, we asked if mitochondrial precursor accumulation caused by Ab can be observed in AD patients. Therefore, we isolated mitochondria from post mortem brain samples of four AD patients and four age-matched non-AD controls (Table S4) . Western blot analysis showed the presence of higher molecular species of the matrix protein MDH2 in all patient samples, but not in controls ( Figure 4E ). An antibody raised against the presequence peptide of MDH2 that recognizes only the precursor, but not the mature, cleaved protein, confirmed the specific accumulation of the MDH2 preproteins in AD mitochondria ( Figure 4F ). In order to identify further mitochondrial proteins that might accumulate as preproteins or processing intermediates in AD patients, we screened various antibodies by western blotting and performed a ChaFRADIC analysis (Venne et al., 2013) . Several proteins could be identified, including the mitochondrial ribosomal subunit MRPL23 and NDUFA9, a subunit of the respiratory complex I ( Figure S3I and Table S5 ). Taken together, our results show that mitochondrial Ab causes impaired maturation of preproteins in vivo. 
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Ab Impairs Mitochondrial Preprotein Maturation DISCUSSION So far, mitochondrial presequence processing and peptide turnover have been considered independent reactions. Our findings indicate a functional coupling of both processes. Presequence processing capacity seems to depend directly on efficient peptide clearance in the matrix, as addition of the peptide-degrading enzyme Cym1 to mitochondrial cym1D extracts immediately restored MPP presequence processing activity in vitro. Moreover, lack of Cym1 leads to accumulation of immature preproteins in vivo, reflecting the mas1 mutant phenotype with impaired presequence processing activity. Accumulating presequence peptides likely bind to the active site of MPP, thereby competing directly with incoming preproteins (Yang et al., 1991; Taylor et al., 2001 ). In both cases-mutations in Cym1 and in Mas1-impaired preprotein maturation causes accelerated protein degradation and results in an imbalanced organellar proteome. As a consequence, various mitochondrial functions are affected, e.g., decreased respiration and membrane potential and increased levels of ROS. Interestingly, similar phenotypes have been observed in AD mitochondria (Morais and De Strooper, 2010; Manczak et al., 2006; Rhein et al., 2009; Alikhani et al., 2011b) . It is still unclear if mitochondrial dysfunction is the cause or consequence of AD and how mitochondrial damage is connected to other cellular dysfunctions observed in AD (Lin and Beal, 2006; Morais and De Strooper, 2010; Treusch et al., 2011) . However, it has been shown that Ab accumulates in mitochondria of AD patients, where it seems to affect similar diverse functions that we found here in cym1D mitochondria. Our results reveal that Ab causes inhibition of the peptidasome PreP/Cym1. In turn, accumulation of presequence peptides leads to impaired maturation and therefore cumulation of mitochondrial preproteins by inhibition of the presequence processing machinery. Indeed, global proteomic studies of AD samples indicated an imbalance of the mitochondrial proteome; presequence-containing mitochondrial proteins in particular were found affected (Rhein et al., 2009; Begcevic et al., 2013) . The results presented here provide a mechanistic model that can explain the diversity of mitochondrial dysfunctions observed in AD ( Figure 4G) . Herein, the presequence processing machinery plays a central role in the age-dependent vicious cycle of mitochondrial dysfunction in AD. Our findings offer exciting perspectives on the development of diagnostic markers (e.g., to detect preproteins in blood cells of patients that were found to possess mitochondrial dysfunctions; Leuner et al., 2012) and therapeutic strategies (e.g., stimulation of the presequence processing machinery) in AD.
EXPERIMENTAL PROCEDURES
Isolation of Mitochondria from Yeast Cells and Mouse and Human Brain Tissue
Mitochondria from S. cerevisiae strains (Table S1) , mouse, and human brain tissues (Table S4) 
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Ab Impairs Mitochondrial Preprotein Maturation Ozmen et al., 2009 ) of 12 months were sacrificed, and brains were removed. Tissue samples of the temporal cortex of human brains were collected post mortem for diagnostic purposes. Cells or tissues were homogenized by 15-30 strokes in a glass potter. Cell debris and nonbroken cells were removed in two consecutive centrifugation steps (484-1,500 3 g, 4 C). Mitochondria were isolated by centrifugation at 7,000-16,000 3 g at 4 C. The mitochondrial fractions were aliquoted, snap frozen in liquid nitrogen, and stored at À80 C. (empty vector). For selection, cells were grown in selective medium lacking histidine and uracil. Expression of plasmids was induced by shift to selective medium containing 2% galactose. Cells were grown at 30 C for 1, 3, or 5 days. Cell extracts were obtained by post-alkaline extraction, and mitochondria were isolated as described above. Samples were analyzed on SDS-PAGE followed by immunodecoration.
Preprotein Processing and Peptide Degradation Assays in
In 
Generation of Radiolabelled Precursors and Chemical Amounts of Peptidases
Radiolabelled preproteins were synthesized by in vitro transcription/translation using the rabbit reticulate lysate system (Promega) in the presence of 35 S-methionine. Chemical amounts of Cym1 (aa 8-989) and control protein (Oct1; aa 29-772) were synthesized using the RTS wheat germ system (5 PRIME).
Statistical Analysis
Quantified data are shown as mean ± SEM and were obtained from at least three independent experiments. 
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